Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-28

Clinical Trial Update: Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects [NA]

View source ↗

Summary

This clinical trial update reports the results of a terminated study examining physiological and cognitive biomarkers linked to ketamine's antidepressant effect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression | NA | Status: TERMINATED | Results posted: 2017-02-28